SMAC

MSX BY MICHAEL STRAHAN™ NAMED OFFICIAL OFF-FIELD APPAREL PARTNER OF THE UNITED FOOTBALL LEAGUE

Retrieved on: 
Wednesday, March 13, 2024
Element, Pro, Growth, SMAC, Sport, UFL, Partnership, United Football League, Official, Business development, NHL, Senior, Athlete, Woman, Collection, MSX, NFL, The

The brand’s licensed apparel collection, MSX by Michael Strahan™ – known for licensed NFL and NHL merchandise – is now the Official Off-Field Apparel Partner of the UFL.

Key Points: 
  • The brand’s licensed apparel collection, MSX by Michael Strahan™ – known for licensed NFL and NHL merchandise – is now the Official Off-Field Apparel Partner of the UFL.
  • As the Michael Strahan Brand approaches its 10th anniversary, this partnership marks the company’s first official league-level category designation.
  • The unique Official Off-Field Apparel Partner designation is reflective of Strahan’s iconic career.
  • The MSX by Michael Strahan™ brand will also be featured prominently in all UFL venues, including in lower-bowl and field-level signage.

OpenGate Capital Enters into Exclusive Discussions to Sell SMAC

Retrieved on: 
Monday, March 4, 2024
Finance, Building Systems, Other Construction & Property, Professional Services, Construction & Property, Acquisition, Andrew Nikou, Colas Group, Membrane, SMAC, Sale

OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has entered into exclusive discussions for the sale of SMAC , a supplier of waterproofing and building envelop systems, to Compagnie Financière Jousset and the SMAC management team.

Key Points: 
  • OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has entered into exclusive discussions for the sale of SMAC , a supplier of waterproofing and building envelop systems, to Compagnie Financière Jousset and the SMAC management team.
  • OpenGate acquired SMAC in 2019 through a corporate carve-out from Colas Group, a subsidiary of Bouygues SA.
  • SMAC was established in 1884 and has grown into a leader in the French waterproofing and facades market.
  • Following the acquisition by OpenGate, SMAC disposed of its manufacturing divisions (membranes, skylights, and resins) to focus on installation.

Deion “Coach Prime” Sanders Named 2023 Sports Illustrated Sportsperson of the Year

Retrieved on: 
Thursday, November 30, 2023
Basketball, Sports, General Sports, Publishing, Entertainment, Volleyball, Communications, Football, Soccer, Film & Motion Pictures, Online, Sale, University of Colorado Boulder, Brawn GP, Sport, Character, SMAC, Pro, LeBron James, Multimedia, Culture, Sports Illustrated, GOAT, Buffalo, NIL, Head cheese, University, Athlete, Amazon Prime Video, Folsom Field, Colorado Buffaloes, Sports equipment, Clothing, Boulder, Shlomi, Deion, Softball, Sanders

Today, Sports Illustrated (SI) revealed Deion Sanders, the University of Colorado Buffaloes head football coach and Pro Football Hall of Famer, as the 2023 Sportsperson of the Year .

Key Points: 
  • Today, Sports Illustrated (SI) revealed Deion Sanders, the University of Colorado Buffaloes head football coach and Pro Football Hall of Famer, as the 2023 Sportsperson of the Year .
  • The strides made in Boulder alone don’t fully explain why Sanders is SI’s 2023 Sportsperson of the Year.
  • “Deion Sanders dominated the sports conversation in 2023 as a transformative figure not just in Colorado, but for the entire realm of college sports,” said Stephen Cannella, Editor in Chief of Sports Illustrated.
  • Follow Sports Illustrated on Twitter @SInow , Instagram @sportsillustrated , and Facebook , or subscribe to Sports Illustrated today.

Medivir to present at the Carlsquare Equity Research Investor Day

Retrieved on: 
Wednesday, December 6, 2023
Nasdaq Stockholm, Drug development, Patient, Partnership, Market capitalization, Cancer, SMAC, Medivir

STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Carlsquare Equity Research Investor Day, today December 6, 2023.

Key Points: 
  • STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Carlsquare Equity Research Investor Day, today December 6, 2023.
  • CEO Jens Lindberg will present at 14.30 CET, with focus on the latest developments and the company's future plans.
  • Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a pro-drug designed to selectively treat liver cancer cells and to minimize side effects.
  • Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership.

Medivir to present at the Redeye Life Science Day

Retrieved on: 
Wednesday, November 22, 2023
Nasdaq Stockholm, Drug development, CET, Patient, Partnership, Market capitalization, Cancer, Red eye, SMAC, Pharmaceutical industry, Medivir

STOCKHOLM, Nov. 22, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Life Science Day, tomorrow November 23, 2023.

Key Points: 
  • STOCKHOLM, Nov. 22, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Life Science Day, tomorrow November 23, 2023.
  • CEO Jens Lindberg will participate in an In Focus interview at 13.20 CET, led by Redeye analyst Richard Ramanius, with focus on the latest developments and the company's future plans.
  • Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a pro-drug designed to selectively treat liver cancer cells and to minimize side effects.
  • Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership.

Data Loss Prevention Market worth $8.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, October 10, 2023
DLP, Identity theft, Acquisition, Rest, Organization, Intelligence, R, Education, BFSI, Social, Managed security service, Encryption, Telecommunications, Cisco, Government, Research and development, Dell, Trend Micro, Communication, Data loss prevention software, Energy and Utility Skills, Data loss, Dell Technologies, Risk, VPN, SMAC, CCPA, Illinois Department of Central Management Services, Fraud, SOC, IBM, Network, Confidentiality, Incident, VMware, Fad, MSSP, GDPR, Automation, Small business, Growth, Maintenance, Privacy, Cloud storage, Television, Risk management, Maintenance (technical), Video game, Cryptocurrency, Retail, Internet service provider, Airline, Broadcom Inc., Microsoft, Health care, Cloud, Policy

A convergence of factors drives North America's Data Loss Prevention (DLP) market.

Key Points: 
  • A convergence of factors drives North America's Data Loss Prevention (DLP) market.
  • Data Loss Prevention Market Advantages:
    DLP systems secure sensitive data by preventing unauthorised access, sharing, or leakage, and thereby protect intellectual property and sensitive information.
  • To determine, segment, and forecast the global Data Loss Prevention Market by offering solution types, services, applications, verticals, and regions in terms of value.
  • To strategically analyze the macro and micro markets to individual growth trends, prospects, and contributions to the total Data Loss Prevention Market
    To analyze the industry trends, pricing data, patents, and innovations related to the Data Loss Prevention Market.

Data Loss Prevention Market worth $8.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, October 10, 2023
DLP, Identity theft, Acquisition, Rest, Organization, Intelligence, R, Education, BFSI, Social, Managed security service, Encryption, Telecommunications, Cisco, Government, Research and development, Dell, Trend Micro, Communication, Data loss prevention software, Energy and Utility Skills, Data loss, Dell Technologies, Risk, VPN, SMAC, CCPA, Illinois Department of Central Management Services, Fraud, SOC, IBM, Network, Confidentiality, Incident, VMware, Fad, MSSP, GDPR, Automation, Small business, Growth, Maintenance, Privacy, Cloud storage, Television, Risk management, Maintenance (technical), Video game, Cryptocurrency, Retail, Internet service provider, Airline, Broadcom Inc., Microsoft, Health care, Cloud, Policy

A convergence of factors drives North America's Data Loss Prevention (DLP) market.

Key Points: 
  • A convergence of factors drives North America's Data Loss Prevention (DLP) market.
  • Data Loss Prevention Market Advantages:
    DLP systems secure sensitive data by preventing unauthorised access, sharing, or leakage, and thereby protect intellectual property and sensitive information.
  • To determine, segment, and forecast the global Data Loss Prevention Market by offering solution types, services, applications, verticals, and regions in terms of value.
  • To strategically analyze the macro and micro markets to individual growth trends, prospects, and contributions to the total Data Loss Prevention Market
    To analyze the industry trends, pricing data, patents, and innovations related to the Data Loss Prevention Market.

Medivir to present at the Pareto Securities Healthcare Conference

Retrieved on: 
Thursday, September 14, 2023
Cancer, Partnership, Drug development, Market capitalization, Patient, Nasdaq Stockholm, Conference, SMAC, Medivir, Pharmaceutical industry

STOCKHOLM, Sweden , Sept. 14, 2023 /PRNewswire/ -- Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Pareto Securities Healthcare Conference, Today, September 14, at 12.55 CET.

Key Points: 
  • STOCKHOLM, Sweden , Sept. 14, 2023 /PRNewswire/ -- Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Pareto Securities Healthcare Conference, Today, September 14, at 12.55 CET.
  • Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high.
  • Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a pro-drug designed to selectively treat liver cancer cells and to minimize side effects.
  • Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership.

Next Gen Learning Management System (LMS) Market for Higher Education to grow by USD 2.59 billion from 2022 to 2027, Blackboard Inc., Blue Sky eLearn, Cornerstone OnDemand Inc. to be key players of the market

Retrieved on: 
Thursday, September 14, 2023
Learning, Blockchain, LMS, Education, Liverpool, SMAC, Blackboard Inc., University, SAP, USD, SAP SE, K–12, Cornerstone, Oracle Corporation, Student, EFront (eLearning software), Geography, CBE, Artificial intelligence, Growth, IBM, Music, Tutoring

The next-gen learning management system (LMS) market for higher education is fragmented owing to the presence of many global and regional companies.

Key Points: 
  • The next-gen learning management system (LMS) market for higher education is fragmented owing to the presence of many global and regional companies.
  • Download FREE Sample before buying
    Blackboard Inc: The company offers next gen Learning Management System (LMS) for higher education namely Blackboard Learn LMS.
  • By Geography, the market is classified as North America, Europe, APAC, South America, and Middle East and Africa.
  • The rise in learning experiences using SMAC is a key trend in the global next-gen learning management system (LMS) market, during the forecast period.

Medivir to present at the Erik Penser Bank Company Event

Retrieved on: 
Wednesday, August 23, 2023
Trial of the century, Medivir, Cancer, Partnership, Drug development, Market capitalization, Patient, Nasdaq Stockholm, SMAC, Pharmaceutical industry

STOCKHOLM, Aug. 23, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Erik Penser Bank Company Event on Thursday, August 24, 2023.

Key Points: 
  • STOCKHOLM, Aug. 23, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Erik Penser Bank Company Event on Thursday, August 24, 2023.
  • CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox) at 09.05 CET.
  • Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high.
  • Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership.